EQUITY (Details) - USD ($)				12 Months Ended
	Apr. 29, 2022	Oct. 31, 2019	Jan. 01, 2019	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jul. 26, 2022	Jul. 25, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares issued (in shares)				55,597,855	53,715,569
Common stock, shares outstanding (in shares)				55,597,855	53,715,569
Issuance of common stock, related expenses				$ 4,900,000	$ 6,600,000
Sale of stock, maximum consideration on transaction	$ 350,000,000
Sale of stock, agreement term	3 years
Sale of stock, number of shares issued in transaction				1,802,063
Proceeds from issuance of common stock, excluding employee stock purchase plans				$ 104,600,000
Payments for commissions				1,100,000
Payments of stock issuance costs				$ 100,000	$ 200,000
Common stock, shares authorized (in shares)				136,000,000	136,000,000		136,000,000	68,000,000
Common stock, par value (in dollars per share)				$ 0.01	$ 0.01		$ 0.01
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares issued (in shares)				40,095	37,460	43,332
Percent of market value discount			90.00%
Maximum payroll deduction			10.00%
Maximum number of shares per employee (in shares)			2,000
Maximum value of shares per employee			$ 25,000
Issuance of common stock, related expenses				$ 200,000	$ 200,000	$ 200,000
Equity Distribution Agreement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payments for commissions					$ 2,000,000
Common stock, shares, sold (in shares)					3,286,865
Proceeds from sale of common stock					$ 195,900,000
Maximum | Equity Distribution Agreement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of common stock, gross sales price		$ 300,000,000